Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
Biopharma intelligence firm Ozmosi has launched a database that aims to include almost all clinical trials around the world.
Antidote, which develops an online platform to match patients with researchers, just raised $11 million backed by Merck's GHI fund.
Insmed aims to bring a first-in-market therapy to patients in the U.S. suffering from NTM lung disease caused by MAC, a chronic and debilitating condition.
Greenphire integrates its patient payment solution into mProve's patient engagement mobile app.
Parexel has set up a team committed to providing real-world data insights.
Outcome Health has tapped Harvard Health Publications to improve and expand its health intelligence offerings.
WIRB-Copernicus Group has bought Patient Genesis’ eConsent technology, ConsentNow.
PRA will buy health data and analytics expert Symphony Health for $530 million up front as it reports 16% second-quarter service revenue growth.
BeiGene is adding Medidata’s electronic patient-reported outcome solution to oncology clinical studies.
SynteractHCR has hired Steve Powell, who has years of experience on electronic data as a senior executive at Exco InTouch and PRA Health Sciences.
Medidata is making new conquests in the clinical trial world, as it just inked a deal to manage site payments for Worldwide Clinical Trials.